[ Price : $8.95]
Members of FDAs Endocrinologic and Metabolic Drugs Advisory Committee recommend approval of BioMarins Vimizim for treating Morquio...[ Price : $8.95]
Federal Register Notice; FDA releases a draft guidance on 510(k) submissions for nucleic acid-based human leukocyte antigen test k...[ Price : $8.95]
Federal Register Final rule: FDA is correcting a minor error in a 2010 final rule amending certain regulations to include tobacco ...[ Price : $8.95]
Perrigo files an ANDA for clindamycin phosphate and benzoyl peroxide gel 1.2%/2.5%, a generic copy of Dow Pharmasciences Acanya.[ Price : $8.95]
FDA clears a TauTona Group 510(k) for the TauTona Tissue Injector, a single-use, hand-held adipose tissue transfer tool for use in...[ Price : $8.95]
Attorneys writing online say FDAs proposed rule to allow generic drug companies to make safety labeling changes could raise new pr...[ Price : $8.95]
CDER says it has refused to accept 497 ANDAs over the past four years (2009-2012) due to application deficiencies.[ Price : $8.95]
CDERs Office of Prescription Drug Promotion warns Kadmon Pharmaceuticals about multiple promotional violations in Ribasphere intro...